This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Book Now
Menu
Book

Andreas Vegge, PhD
Project Vice President, Amycretin Cardiometabolics at Novo Nordisk
Speaker

Agenda Sessions

  • GLP-1 and Amylin Agonist Amycretin

    , 15:50
    View Session

At this event

Prev
Next
Yang Wang
Deputy Head of Molecular Biology Product Marketing
GenScript

See Andreas at TIDES Europe: Oligonucleotide and Peptide Therapeutics

Book Now